As an alternative to FDA-approved branded products, where appropriate, a provider may prescribe a compounded drug, which is prepared by a state-licensed sterile compounding pharmacy partner
Common Protocol: CJC-1295: 100200 mcg 12x daily, subcutaneous Ipamorelin: 100200 mcg 12x daily, subcutaneous (often injected together with CJC-1295) Cycle: 812 weeks, can be run longer depending on goals 4
Portability and ease: It fits more easily into a regular bedtime routine you dont need to prepare needles, swabs, or worry about injection sites
The legal position in New Zealand Most peptides sold here are unapproved medicines, Medsafe hasn't evaluated them for quality, safety, or efficacy
Most patients require only a single treatment
For athletes, record relevant performance metrics